SOUTH SAN FRANCISCO, Calif., April 28, 2022 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that Board member Hannah Valantine MD, a recognized leader in driving heart transplantation innovations and health equity, has received the 2022 Lifetime Achievement Award from the International Society for Heart and Lung Transplantation (ISHLT). Read the full press release on CareDx.com here.
CareDx Extends Artificial Intelligence Leadership to Heart Transplantation
New Addition to CareDx HeartCare Multimodality Portfolio Can Enable More Precise, Personalized Patient Care
SOUTH SAN FRANCISCO, Calif., April 28, 2022 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that through its ongoing partnership with OrganX, a non-profit health organization focused on cutting-edge digital health solutions, it plans to expand its HeartCare multimodality portfolio with a new artificial intelligence (AI) prognostic for cardiac allograft vasculopathy (CAV).
Read the complete press release on CareDx.com.
5 Big Benefits of Living Donation for the Donor
You probably have heard of the enormous benefits of a living vs. deceased-donor kidney for the recipient, but did you know that there are real benefits to the donor, too?
For family members or couples, they are nothing short of dramatic:
1. Helping a loved one is an amazing feeling: To see a loved one who’s been pale, weak, and often listless for many months or years gradually become their old self again is pretty powerful. Before I donated my kidney to my son in 2006, his 20 months on dialysis had left him lethargic and depressed; seeing his smile when he came into my hospital room the day after the transplant was unforgettable. Read the full story from National Kidney Foundation here.
CareDx CEO and President, Reg Seeto, Joins ISHLT Foundation Global Steering Committee Focused on Driving Innovations for Heart and Lung Transplant Patients
SOUTH SAN FRANCISCO, Calif., April 27, 2022 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced Reg Seeto’s selection by the newly formed International Society for Heart and Lung Transplantation (ISHLT) Foundation to serve as Corporate Chair of the organization’s Global Steering Committee. Reg Seeto, MB.BS, will join Fundraising Chair Frank Pagani, MD and Foundation Chair James Kirklin, MD to help drive a multiyear campaign, the “Fostering Excellence Campaign,” which is focused on vitally important research to improve outcomes for patients with advanced heart and lung disease and organ transplants.
Read the full press release on CareDx.com here.
Vital Signs: Working to better preserve hearts for transplants
Studies have shown that hearts and other donor organs are very sensitive to the temperatures at which they are preserved during transport. Temperatures below 2 degrees Celsius have been shown to have a negative effect on outcomes for transplant patients and potentially be linked to complications related to the viability of a donor organ for transplant.
Read the full story in The Daily Progress.
Kidney Brothers Develop Bond for Life
What happened between two families at Stanford Children’s Health bonded them forever.
While awaiting kidney transplants for their young boys, the two families—one from Hawaii, one from California—became friends. Families often become close during the long hours of dialysis, but they don’t often hear the hopeful news that a donor kidney might be a match on the same day. Read the full story from Stanford Children’s Health here.
Vital Signs: Working to better preserve hearts for transplant
Studies have shown that hearts and other donor organs are very sensitive to the temperatures at which they are preserved during transport. Temperatures below 2 degrees Celsius have been shown to have a negative effect on outcomes for transplant patients and potentially be linked to complications related to the viability of a donor organ for transplant.
Another challenge is related to the lack of data related to organ conditions during transport. With the standard method of preserving organs — packing them in ice — it is difficult to know the precise temperature at which a donated organ is being preserved during transport. Read the full article in The Daily Progress.
Traveling While on Dialysis? Start Here.
Now that summer is approaching, many of our minds have turned to vacation plans. Whether you imagine relaxing on sandy beaches, tubing on a snow-capped mountain, or taking a tour around a city, here’s how to prepare for traveling while on dialysis.
Read the complete article from National Kidney Foundation here.
Mayo Clinic Minute: ‘Liver in a box’ is saving lives with new technology
It is new technology called “liver in a box,” and it’s improving outcomes for patients who receive lifesaving transplants.
April is National Donate Life Month, which helps raise awareness about the importance of organ donation. According to Lifesource, more than 11,000 people in the U.S. are waiting for a lifesaving liver donation. Read more in Medical Xpress.
How has COVID-19 affected Organ Transplantation?
The retrovirus coronavirus disease 2019 (COVID-19) has had a profound impact on all facets of the medical industry. Media and medical experts alike have held a keen focus on, and have requested the aid of otolaryngologists, virologists, and general respiratory equipment. However, many auxiliary branches of medicine are being affected by the COVID-19 virus. Read the complete article in News Medical.